Siren L.L.C. Acquires Shares of 277,533 Rhythm Pharmaceuticals, Inc. $RYTM
MarketBeat
Siren L.L.C. bought a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 277,533 shares of the company's stock, valued at approximately $14,701,000.
NASDAQ:RYTM